Description
Global Electrotherapy Market Overview
The electrotherapy market is anticipated to record a healthy CAGR of 5.10% during the review period, to surpass USD 1,463.74 million by the end of 2027. The factors expected to propel the global market growth are the growing prevalence of sports injuries, technological advancements and new product launches, and rising healthcare expenditure.
The development of the electrotherapy market is driven by the innovative progressions in electrotherapy frameworks, expanding corpulence, rising number of sports wounds, and expanding medical services consumption are the main considerations driving the development of the worldwide electrotherapy market.
Notwithstanding, the absence of mindfulness about the utilization of electrotherapy frameworks in non-industrial nations; accessibility of many substitutes; and immersion in created nations are upsetting the development of this market.
Also, aside from public consumption of medical services, a few speculations by makers, financial speculators, and new items in the worldwide intracranial drain finding and therapy market are relied upon to drive the market development.
Market Segmentation
The electrotherapy market is classified into treatment type, device type, application, and end-user.
Based on treatment type, the market has been classified into extracorporeal shock wave therapy, interferential current therapy (IC), magnetic field therapy, ultrasound therapy, transcutaneous electrical nerve stimulation (TENS) therapy, micro-current therapy, transcutaneous spinal electro analgesia (TSE), pulsed short wave diathermy (PSWD), spinal cord stimulation (SCS), percutaneous electrical nerve stimulation (PENS), and others.
Based on device type, the global electrotherapy market has been classified into transcutaneous electrical neural stimulator (TENS), electronic muscle stimulator (EMS), the interferential stimulator (IF), high voltage pulsed galvanic stimulator (HVPGS), microcurrent stimulator (MC), or microcurrent electrical neuromuscular stimulator (MENS), and others.
In terms of application the market has been categorized into pain management, neuromuscular dysfunction, urine and fecal incontinence, acute and chronic edema, tissue repair, iontophoresis, orthopedics, cardiology, and others. The pain management segment is again segmented into chronic pain, chronic fatigue, migraine headaches, wound healing, diabetic nerve pain, stimulating bone growth, and others.
Based on end-users the electrotherapy market is divided into hospitals & clinics, rehabilitation centers, long-term care centers, and others.
Regional Analysis
Geographically, the electrotherapy market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas led the market in 2019 and is probably going to keep on directing during the appraisal time frame because of the set up medical services foundation, developing mindfulness identified with electrotherapy, and the presence of central members in the area.
The European electrotherapy market has been partitioned into Western Europe and Eastern Europe. The Western Europe electrotherapy market has additionally been arranged into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe.
Europe would follow the Americas as far as worth during the figure time frame because of the expanding geriatric populace, the rising commonness of constant and way of life-related conditions, created medical care infrastructure, and high medical services spending.
Major Players
The major players operating in global electrotherapy market are Medtronic plc (Ireland), Alimed, Inc (US), Cogentix Medical, Inc. (US), Jude Medical Inc. (US), Zynex Medical (US), DJO Global, Inc. (US), Livanova Plc (UK), Nervo Corp (US), Neuromextrix Inc. (US), and Boston Scientific Corporation (US)
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Global Cancer Immunotherapy Market Forecast 2021-2029
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING INCIDENCE OF SPORTS INJURIES
4.2.2 TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCH
4.2.3 INCREASING HEALTHCARE EXPENDITURE
4.3 RESTRAINTS
4.3.1 LACK OF PHYSIOTHERAPISTS AND STRINGENT REGULATORY NORMS
4.4 OPPORTUNITIES
4.4.1 HIGH MARKET GROWTH TO SUPPORT NEW PRODUCT LAUNCH
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE ELECTROTHERAPY MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON SUPPLY CHAIN
5.3.3 IMPACT ON DEMAND FOR ELECTROTHERAPY
5.3.4 INCREASED ADOPTION OF ELECTROTHERAPY
6 GLOBAL ELECTROTHERAPY MARKET, BY TREATMENT TYPE
6.1 OVERVIEW
6.2 EXTRACORPOREAL SHOCK WAVE THERAPY
6.3 INTERFERENTIAL CURRENT THERAPY (IC)
6.4 MAGNETIC FIELD THERAPY
6.5 ULTRASOUND THERAPY
6.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) THERAPY
6.7 MICRO-CURRENT THERAPY
6.8 TRANSCUTANEOUS SPINAL ELECTRO ANALGESIA (TSE)
6.9 PULSED SHORT WAVE DIATHERMY (PSWD)
6.10 SPINAL CORD STIMULATION (SCS)
6.11 PERCUTANEOUS ELECTRICAL NERVE STIMULATION (PENS)
6.12 OTHERS
7 GLOBAL ELECTROTHERAPY MARKET, BY DEVICE TYPE
7.1 OVERVIEW
7.2 TRANSCUTANEOUS ELECTRICAL NEURAL STIMULATOR (TENS)
7.3 ELECTRONIC MUSCLE STIMULATOR (EMS)
7.4 INTERFERENTIAL STIMULATOR (IF)
7.5 HIGH VOLTAGE PULSED GALVANIC STIMULATOR (HVPGS)
7.6 MICROCURRENT STIMULATOR (MC) OR MICROCURRENT ELECTRICAL NEUROMUSCULAR STIMULATOR (MENS)
7.7 OTHERS
8 GLOBAL ELECTROTHERAPY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PAIN MANAGEMENT
8.3 NEUROMUSCULAR DYSFUNCTION
8.4 URINE AND FECAL INCONTINENCE
8.5 ACUTE AND CHRONIC EDEMA
8.6 TISSUE REPAIR
8.7 IONTOPHORESIS
8.8 ORTHOPAEDICS
8.9 CARDIOLOGY
8.10 OTHERS
9 GLOBAL ELECTROTHERAPY MARKET, BY END USERS
9.1 OVERVIEW
9.2 HOSPITALS & CLINICS
9.3 REHABILITATION CENTRES
9.4 LONG-TERM CARE CENTRES
9.5 OTHERS
10 GLOBAL ELECTROTHERAPY MARKET, BY REGION
10.1 OVERVIEW
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.2.2 LATIN AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL ELECTROTHERAPY MARKET
11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ELECTROTHERAPY MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT LAUNCHES/PRODUCT APPROVALS
11.6.2 MERGERS/ACQUISITIONS
11.6.3 PARTNERSHIPS/AGREEMENTS
12 COMPANY PROFILES
12.1 MEDTRONIC PLC
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 ALIMED, INC.
12.2.1 COMPANY OVERVIEW
12.2.4 KEY DEVELOPMENTS
12.3 COGENTIX MEDICAL, INC.
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 ST. JUDE MEDICAL INC.
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 ZYNEX MEDICAL
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 DJO GLOBAL INC.
12.6.1 COMPANY OVERVIEW
12.6.4 KEY DEVELOPMENTS
12.7 LIVANOVA PLC
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SERVICES OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 NEVRO CORP
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 NEUROMETRIX INC.
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SERVICES OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 BOSTON SCIENTIFIC CORPORATION
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
